Ameliorated Pap Tests and Cervical Cancer Screening Participation

Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · May 5, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new way to improve participation in cervical cancer screening using Pap tests. The researchers are testing a method that adds a non-painful step at the end of the Pap smear process, which aims to make the experience less uncomfortable and encourage more women to get screened. The goal is to see if this approach can help women who have never had a Pap test or haven't had one in the last three years, as these women are at a higher risk for cervical cancer.

To be eligible for the trial, women must be 25 years or older and meet certain criteria, such as not currently menstruating, not being pregnant, and not having any active cancer. Participants can expect to undergo a Pap test with this new method and provide feedback on their experience. This trial is important because it could lead to better screening rates and early detection of cervical cancer, which can significantly improve outcomes for women.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women aged 25 or above who have never undergone Pap tests or have not undergone Pap tests in the past 3 years.
• Exclusion Criteria:
• • Ongoing menstruation
• • Pregnancy
• • Incapability of understanding the numeric pain scales
• • Any active cancer at study entry (defined as cancer diagnosed or treated within the previous 6 months, recurrent, regionally advanced or metastatic cancer)
• • Previous hysterectomy, pelvic or vaginal surgery
• • Active vaginal or uterus infection
• • Analgesic use within 24 hours